LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000083 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 2, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
15,000
Total Value
$1,396,665.57
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 5,000 | $52.27 | $261,350.00 | 46,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 491 | $223.95 | $109,957.83 | 45,891 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 677 | $225.20 | $152,459.25 | 45,214 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 1,432 | $225.97 | $323,585.03 | 43,782 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 400 | $226.78 | $90,711.76 | 43,382 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 584 | $228.57 | $133,487.10 | 42,798 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 1,216 | $229.47 | $279,032.60 | 41,582 | Direct | โ | View Details | |
CLO & Secretary | Common Stock | โ | Jun 1, 2026 | Sale | 200 | $230.41 | $46,082.00 | 41,382 | Direct | โ | View Details | |
CLO & Secretary | Employee Stock Option (right to buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 39,444 | Direct | โ | View Details |